Preferences help
enabled [disable] Abstract
Number of results
2009 | 4 | 3 | 363-368
Article title

Aplastic anaemia in childhood. Description of two cases and review of the literature

Title variants
Languages of publication
Childhood aplastic anaemia (AA) is an uncommon but potentially fatal haematological disorder. Patients with AA receive supportive care based on transfusions and timely treatment of opportunistic infections, along with specific therapies, which may be bone marrow transplantation and immunosuppressive therapy. Early diagnosis and supportive therapy are required to prevent fatal complications like overwhelming sepsis or life threatening haemorrhages. We report two cases of aplastic anaemia having a different aetiology. The diagnostic work-up and the therapeutic management for each case are described below.
Physical description
1 - 9 - 2009
3 - 7 - 2009
  • Division of Paediatric Oncology, Catholic University of Rome, 00168, Rome, Italy
  • Division of Paediatric Oncology, Catholic University of Rome, 00168, Rome, Italy
  • Division of Paediatric Oncology, Catholic University of Rome, 00168, Rome, Italy
  • Division of Paediatric Oncology, Catholic University of Rome, 00168, Rome, Italy
  • Division of Paediatric Oncology, Catholic University of Rome, 00168, Rome, Italy
  • Division of Paediatric Oncology, Catholic University of Rome, 00168, Rome, Italy
  • Division of Paediatric Oncology, Catholic University of Rome, 00168, Rome, Italy
  • Division of Paediatric Oncology, Catholic University of Rome, 00168, Rome, Italy
  • [1] Kojima S, Matsuyama T, Kato, S, Kigasawa H, Kobayashi R, Kikuta A., Sakamaki H, Ikuta K, Tsuchida, M., Hoshi Y, Morishima Y, Kodera Y. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 2002;100:799–803[Crossref]
  • [2] Locasciulli A. Acquired aplastic anemia in children: incidence, prognosis and treatment options. Paediatric Drugs 2002;4:761–766 [Crossref]
  • [3] Young NS. Aplastic anaemia. Lancet 1995; 346:228–832[Crossref]
  • [4] The International Agranulocytosis and Aplastic Anemia Study. Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood 1987;70:1718–1721
  • [5] Hirano N, Butler MO, Von Bergwelt-Baildon MS, Maecker B, Schultze, JL, O’Connor KC, Schur PH, Kojima S, Guinan EC, Nadler LM. Autoantibodies frequently detected in patients with aplastic anemia. Blood 2003;102:4567–4575[Crossref]
  • [6] Zeng W, Kajigaya S, Chen G, Risitano AM, Nunez O, Young NS. Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients. Exp Hematol, 2004;32:806–814
  • [7] Sloand E. Genetic polymorphisms and the risk of acquired idiopathic aplastic anemia. Haematologica 2005;90:1009B
  • [8] Dufour C, Capasso M, Svahn J, et al. Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br J Haematol 2004;126:682–685[Crossref]
  • [9] Gidvani V, Ramkissoon S, Sloand EM, Young NS. Cytokine gene polymorphisms in acquired bone marrow failure. Am J Hematol 2007;82:721–724[Crossref][WoS]
  • [10] Muir KR, Chilvers CE, Harriss C, et al. The role of occupational and environmental exposures in the aetiology of acquired severe aplastic anaemia: a case control investigation. Br J Haematol 2003;123:906–914[Crossref]
  • [11] Yanez Rubal JC, Estevez Rodriguez J, Crespo-Lopez MC, Martin- Herranz I. Carbamazepine-induced aplastic anaemia: a case report. Rev Neurol 2002;35:647–649
  • [12] Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitis associated aplastic anemia. N Engl J Med. 1997;336:1059–1064[Crossref]
  • [13] Park CY, Kim HJ, Kim YJ, et al. Very severe aplastic anemia appearing after thymectomy. Korean J Intern Med 2003;18(1):61–63
  • [14] Deka D, Malhotra N, Sinha A, Banerjee N, Kashyap R, Roy KK. Pregnancy associated aplastic anemia: maternal and fetal outcome. J Obstet Gynaecol Res 2003;29(2):67–72 [Crossref]
  • [15] Schrezenmeier H, Hertenstein B, Wagner B, Raghavachar A, Heimpel H. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp Hematol 1995; 23(1):81–87
  • [16] Kim I, Yoon SS, Park S, Kim BK, Kim NK. The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea. J Korean Med Sci 2003;18:365–371[Crossref]
  • [17] Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad II, Kontoyiannis DP. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer 2003;98(1):86–93[Crossref]
  • [18] Bhatnagar, S.K., Chandra, J., Narayan, S., Sharma, S., Singh, V. & Dutta, A.K. Pancytopenia in children: etiological profile. J Trop Pediatr 2005;51: 236–239[Crossref]
  • [19] Safadi R, Or R, Ilan Y, Naparstek E, Nagler A, Klein A, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant 2001;27:183–190[Crossref]
  • [20] Sieff CA, Nisbet-Brown E, Nathan DG. Congenital bone marrow failure syndromes. Br J Haematol. 2000;111:30–42[Crossref]
  • [21] Locasciulli, A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, et al. Outcome of patients with acquired aplastic anaemia given first line bone marrow transplantation or immunosuppression treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007; 92:10–17[Crossref]
  • [22] Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, et al. Long-term outcome after bone marrow transplantation for severe aplastic anaemia. Blood 2004;103:2490–2497[Crossref]
  • [23] Kahl C, Leisenring W, Deeg HJ, Chauncey TR, Flowers ME, Martin PJ, et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long term follow up. Br J Haematol 2005;130:747–751[Crossref]
  • [24] Champlin RE, Perez WS, Passweg J, Klein JP, Camitta BM, Gluckman E, et al. Addition of antithymocyte globulin (ATG) to cyclophosphamide (Cy) for HLA-identical sibling allogeneic bone marrow transplantation (BMT) for severe aplastic anaemia (SAA): results of a randomized controlled trial. Blood 2003;269a
  • [25] Fouladi M, Herman R, Rolland-Grinton M, et al. Improved survival in severe acquired aplastic anemia in childhood. Bone Marrow Transplant 2000;26:1149–1156[Crossref]
  • [26] Kojima S, Horibe K, Inaba J, et al. Long-term outcome of acquired aplastic anemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol 2000;111:321–328[Crossref]
  • [27] Schrezenmeier H, Marin P, Raghavachar A, McCann S, Hows J, Gluckman E, et al. Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol 1993;85:371–377[Crossref]
  • [28] Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H. The German Aplastic Anemia Study Group. Antithymocyte globulin with or without cyclosporin A: 11- year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 2003;101:1236–1242[Crossref]
  • [29] Socie G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A. Late clonal diseases of treated aplastic anemia. Semin Hematol 2000;37:91–101[Crossref]
  • [30] Rosenfeld S, Follman D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between haematologic response and long-term outcome. JAMA 2003;289:1130–1135[Crossref]
  • [31] Scheinberg P, Nunez O, Young R. Re-treatment with rabbit antithymocyte globulin and cyclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol 2006; 133:622–627[Crossref]
  • [32] Marsh JC, Socie G, Schrezenmeier H, Tichelli A, Gluckman E, Ljungman P, et al. Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia. Lancet 1994;344:172–173[Crossref]
  • [33] Scheinberg P, Wu CO, Nunez O, Young NS. Predicting response and survival or severe aplastic anemia patients treated with immunosuppression. ASH Annual Meeting Abstracts 2007;110:504a
  • [34] Fang JP, Xu HG, Huang SL, Chen C, Huang K. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine. Pediatr Hematol Oncol 2006;23:45–50[Crossref]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.